Figure 4.
Multivariate analyses of the combined impact of CMV infection by day 180, donor source, and PTCy. Impact on nonrelapse mortality (A), overall survival (B), relapse (C), and chronic GVHD (D). Notable pairwise comparisons from multivariable analysis are also presented in supplemental Table 5.